Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders

作者: Tetsuro Kikuchi , Tsuyoshi Hirose , Taro Iwamoto

DOI:

关键词:

摘要: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) serotonin reuptake inhibitor in pharmaceutically acceptable carrier. may be aripiprazole or metabolite thereof, which is dopamine-serotonin system stabilizer. fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline escitalopram. useful for treating patients with mood disorders, particularly depression major depressive disorder.

参考文章(158)
V Swanson, K G Power, R J Simpson, D M Sharp, J A Anstee, Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care. British Journal of General Practice. ,vol. 47, pp. 150- 155 ,(1997)
C Michael White, Ronald A Gailey, Gary M Levin, Thomas Smith, Seizure resulting from a venlafaxine overdose. Annals of Pharmacotherapy. ,vol. 31, pp. 178- 180 ,(1997) , 10.1177/106002809703100209
S R Marder, T Van Putten, Behavioral toxicity of antipsychotic drugs. The Journal of Clinical Psychiatry. pp. 13- 19 ,(1987)
Charles M Beasley Jr, Gary Tollefson, Pierre Tran, Winston Satterlee, Todd Sanger, Susan Hamilton, Olanzapine HGAD Study Group, Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacology. ,vol. 14, pp. 111- 123 ,(1996) , 10.1016/0893-133X(95)00069-P
M Sharma, N P Nair, Neurochemical and receptor theories of depression. Psychiatric journal of the University of Ottawa : revue de psychiatrie de l'université d'ottawa. ,vol. 14, pp. 328- 351 ,(1989)
Henry A. Nasrallah, Hans-Jürgen Möller, Treatment of bipolar disorder. The Journal of Clinical Psychiatry. ,vol. 64, pp. 9- 17 ,(2003)